JB Chemicals and Pharma Q3 Results: Profit up 22% as domestic biz outpaces market

SUMMARY

AI Generated Content
  • JB Pharma Q3 FY26 profit up 21.6% to ₹162.5 crore.
  • Revenue grew 14.1% to ₹963.5 crore; margins expanded.
  • Domestic and international businesses showed broad-based growth.
AD
AD